Management will formalise access to individuals with antimicrobial prescribing expertise (eg: pharmacist or general practitioner) Management will ensure that all clinical staff can access current endorsed national guidelines on antimicrobial prescribing. Management will ensure that mechanisms are in place to enable staff to access medical assessment and antimicrobials in a timely way for patients with acute infections. Management will require endorsed guidelines for appropriate diagnostic testing (eg: correctly obtaining microbiological specimens) for specific infections are followed. Management will ensure a system is in that enables diagnostic test results to be reviewed in a timely way. Management will require that if an antimicrobial is prescribed, the resident is clinically assessed by the prescriber within 48 Management will require that if an antimicrobial is prescribed all key prescribing elements are documented. Management will require all new antimicrobial prescriptions are reviewed within seven days and all prolonged antimicrobial prescriptions are reviewed at least half yearly. Management will ensure a resident with a suspected infection, and/or carer, receives information on their health condition and treatment options in a format and language that they can understand. Management will specify a person who is responsible for leading and co-ordinating AMS initiatives. The nominated AMS person has the authority to review all procedures and guidelines that contain recommendations for the use of antimicrobials to ensure that the advice is evidence where possible and concordant with AMS principles. The nominated AMS person has the authority to lead at least annual audits of infections and antimicrobial prescribing practices. The nominated AMS person is expected to provide reports to management regarding prescribing performance and should provide clinically meaningful feedback to clinicians.
Management will formalise access to individuals with antimicrobial prescribing expertise (eg: pharmacist or general practitioner) Management will ensure that all clinical staff can access current endorsed national guidelines on antimicrobial prescribing. Management will ensure that mechanisms are in place to enable staff to access medical assessment and antimicrobials in a timely way for patients with acute infections. Management will require endorsed guidelines for appropriate diagnostic testing (eg: correctly obtaining microbiological specimens) for specific infections are followed. Management will ensure a system is in that enables diagnostic test results to be reviewed in a timely way. Management will require that if an antimicrobial is prescribed, the resident is clinically assessed by the prescriber within 48 Management will require that if an antimicrobial is prescribed all key prescribing elements are documented. Management will require all new antimicrobial prescriptions are reviewed within seven days and all prolonged antimicrobial prescriptions are reviewed at least half yearly. Management will ensure a resident with a suspected infection, and/or carer, receives information on their health condition and treatment options in a format and language that they can understand. Management will specify a person who is responsible for leading and co-ordinating AMS initiatives. The nominated AMS person has the authority to review all procedures and guidelines that contain recommendations for the use of antimicrobials to ensure that the advice is evidence where possible and concordant with AMS principles. The nominated AMS person has the authority to lead at least annual audits of infections and antimicrobial prescribing practices. The nominated AMS person is expected to provide reports to management regarding prescribing performance and should provide clinically meaningful feedback to clinicians.
AMS_Policy_Final_August_2018.docx